UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis
NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD
Overall UFPT gets a fundamental rating of 6 out of 10. We evaluated UFPT against 190 industry peers in the Health Care Equipment & Supplies industry. UFPT has an excellent profitability rating, but there are some minor concerns on its financial health. UFPT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, UFPT could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
UFPT had positive earnings in the past year.
In the past year UFPT had a positive cash flow from operations.
In the past 5 years UFPT has always been profitable.
Each year in the past 5 years UFPT had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 8.49%, UFPT belongs to the best of the industry, outperforming 89.89% of the companies in the same industry.
UFPT's Return On Equity of 16.47% is amongst the best of the industry. UFPT outperforms 92.55% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.61%, UFPT belongs to the top of the industry, outperforming 90.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is in line with the industry average of 8.19%.
The last Return On Invested Capital (10.61%) for UFPT is above the 3 year average (9.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.49% | ||
| ROE | 16.47% | ||
| ROIC | 10.61% |
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%
1.3 Margins
Looking at the Profit Margin, with a value of 11.74%, UFPT belongs to the top of the industry, outperforming 88.30% of the companies in the same industry.
In the last couple of years the Profit Margin of UFPT has grown nicely.
With an excellent Operating Margin value of 15.83%, UFPT belongs to the best of the industry, outperforming 86.17% of the companies in the same industry.
In the last couple of years the Operating Margin of UFPT has grown nicely.
UFPT has a Gross Margin of 28.31%. This is in the lower half of the industry: UFPT underperforms 77.13% of its industry peers.
UFPT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.83% | ||
| PM (TTM) | 11.74% | ||
| GM | 28.31% |
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%
2. Health
2.1 Basic Checks
UFPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
UFPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UFPT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.94 indicates that UFPT is not in any danger for bankruptcy at the moment.
UFPT has a Altman-Z score of 5.94. This is amongst the best in the industry. UFPT outperforms 82.45% of its industry peers.
The Debt to FCF ratio of UFPT is 4.67, which is a neutral value as it means it would take UFPT, 4.67 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.67, UFPT belongs to the best of the industry, outperforming 80.85% of the companies in the same industry.
UFPT has a Debt/Equity ratio of 0.61. This is a neutral value indicating UFPT is somewhat dependend on debt financing.
UFPT has a worse Debt to Equity ratio (0.61) than 68.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.67 | ||
| Altman-Z | 5.94 |
ROIC/WACC1.18
WACC9.01%
2.3 Liquidity
UFPT has a Current Ratio of 2.57. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of UFPT (2.57) is comparable to the rest of the industry.
UFPT has a Quick Ratio of 1.43. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT's Quick ratio of 1.43 is on the low side compared to the rest of the industry. UFPT is outperformed by 61.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.57 | ||
| Quick Ratio | 1.43 |
3. Growth
3.1 Past
UFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.86%, which is quite impressive.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
The Revenue has grown by 18.48% in the past year. This is quite good.
The Revenue has been growing by 16.00% on average over the past years. This is quite good.
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%
3.2 Future
UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.27% yearly.
UFPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.77% yearly.
EPS Next Y29.29%
EPS Next 2Y22%
EPS Next 3Y19.27%
EPS Next 5YN/A
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 36.31, which means the current valuation is very expensive for UFPT.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 71.81% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. UFPT is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 29.23, which means the current valuation is very expensive for UFPT.
73.40% of the companies in the same industry are more expensive than UFPT, based on the Price/Forward Earnings ratio.
UFPT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.31 | ||
| Fwd PE | 29.23 |
4.2 Price Multiples
UFPT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. UFPT is cheaper than 72.87% of the companies in the same industry.
76.06% of the companies in the same industry are more expensive than UFPT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.95 | ||
| EV/EBITDA | 26.06 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
A more expensive valuation may be justified as UFPT's earnings are expected to grow with 19.27% in the coming years.
PEG (NY)1.24
PEG (5Y)1.6
EPS Next 2Y22%
EPS Next 3Y19.27%
5. Dividend
5.1 Amount
UFPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
254.56
-12.44 (-4.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change9.92%
Ins OwnersN/A
Ins Owner Change7.74%
Market Cap1.95B
Analysts80
Price Target388.62 (52.66%)
Short Float %12.22%
Short Ratio8.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)12.38%
Max EPS beat(2)14.29%
EPS beat(4)4
Avg EPS beat(4)25.88%
Min EPS beat(4)12.38%
Max EPS beat(4)46.43%
EPS beat(8)7
Avg EPS beat(8)18.43%
EPS beat(12)11
Avg EPS beat(12)34.1%
EPS beat(16)14
Avg EPS beat(16)30.76%
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)0.98%
Max Revenue beat(2)7.43%
Revenue beat(4)4
Avg Revenue beat(4)4.87%
Min Revenue beat(4)0.98%
Max Revenue beat(4)7.43%
Revenue beat(8)7
Avg Revenue beat(8)3.66%
Revenue beat(12)11
Avg Revenue beat(12)6.82%
Revenue beat(16)14
Avg Revenue beat(16)5.61%
PT rev (1m)0%
PT rev (3m)0.66%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.17%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.98%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.31 | ||
| Fwd PE | 29.23 | ||
| P/S | 4.23 | ||
| P/FCF | 42.95 | ||
| P/OCF | 35.58 | ||
| P/B | 5.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 26.06 |
EPS(TTM)7.01
EY2.75%
EPS(NY)8.71
Fwd EY3.42%
FCF(TTM)5.93
FCFY2.33%
OCF(TTM)7.15
OCFY2.81%
SpS60.21
BVpS42.91
TBVpS-1.34
PEG (NY)1.24
PEG (5Y)1.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.49% | ||
| ROE | 16.47% | ||
| ROCE | 13.05% | ||
| ROIC | 10.61% | ||
| ROICexc | 10.93% | ||
| ROICexgc | 29.09% | ||
| OM | 15.83% | ||
| PM (TTM) | 11.74% | ||
| GM | 28.31% | ||
| FCFM | 9.84% |
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%
ROICexc(3y)9.58%
ROICexc(5y)9.84%
ROICexgc(3y)21.67%
ROICexgc(5y)20.24%
ROCE(3y)11.55%
ROCE(5y)11.63%
ROICexcg growth 3Y23.9%
ROICexcg growth 5Y9.52%
ROICexc growth 3Y17.37%
ROICexc growth 5Y6.42%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%
F-Score5
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.67 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 72.29% | ||
| Cap/Sales | 2.04% | ||
| Interest Coverage | 14.27 | ||
| Cash Conversion | 63.72% | ||
| Profit Quality | 83.86% | ||
| Current Ratio | 2.57 | ||
| Quick Ratio | 1.43 | ||
| Altman-Z | 5.94 |
F-Score5
WACC9.01%
ROIC/WACC1.18
Cap/Depr(3y)90.69%
Cap/Depr(5y)79.13%
Cap/Sales(3y)3.04%
Cap/Sales(5y)2.9%
Profit Quality(3y)44.68%
Profit Quality(5y)83.37%
High Growth Momentum
Growth
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
EPS Next Y29.29%
EPS Next 2Y22%
EPS Next 3Y19.27%
EPS Next 5YN/A
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y30.99%
EBIT growth 3Y49.79%
EBIT growth 5Y22.92%
EBIT Next Year74.72%
EBIT Next 3Y31.27%
EBIT Next 5YN/A
FCF growth 1Y496.37%
FCF growth 3Y14.27%
FCF growth 5Y14.19%
OCF growth 1Y11575.1%
OCF growth 3Y18.18%
OCF growth 5Y14.16%